You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. ROBOT: Rules Oriented Blockchain Operations Transactor

    SBC: EMERGENT SPACE TECHNOLOGIES, INC.            Topic: T11

    Emergent Space Technologies (Emergent) proposes to develop ROBOT, the Rules Oriented Blockchain Operations Transactor. ROBOT extends Blockchain technology to the space domain, enabling essential autonomy for distributed spacecraft resource scheduling and tasking. In the ground segment of federated systems, where NASA does not control all resources, ROBOT enables system users to securely and transp ...

    STTR Phase I 2019 National Aeronautics and Space Administration
  2. Mars/Interplanetary Swarm Design and Evaluation Framework (MISDEF)

    SBC: ORBIT LOGIC INCORPORATED            Topic: T4

    Addressing the needs of Mars exploration missions in the NASArsquo;s strategic plan will require robust and effective autonomous collaborative operations between heterogeneous assets. These ldquo;swarmsrdquo; may consisting of ground rovers, atmospheric craft and Mars-orbiting satellites. To maximize the satisfaction of overall mission objectives, be tolerant of faults/anomalies, and minimize the ...

    STTR Phase I 2019 National Aeronautics and Space Administration
  3. Evaluation of therapeutic efficacy and safety of novel small RNA target delivery platform in vivo.

    SBC: Oncoimmune Inc            Topic: 100

    Project Summary AbstractThe recent rapid expansion of genomic data greatly contributes to the understanding of disease development and progressionTo translate these genetic discoveries into clinical applicationswe need to develop therapeutic platforms that can specifically modulate the expression of disease related genes in vivoSmall RNAssuch as microRNAs and siRNAs function in messenger RNA silen ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  4. Coherence Gated Doppler for Dentistry

    SBC: CREATV MICROTECH INC            Topic: NIDCR

    AbstractIf there were a simple and accurate means totake the pulseof a toothi efunctionally similar to a pulse oximeter that could be clipped on a tooth rather than the tip of a fingerthe quality and cost of dental care would be significantly improvedThe ability to measure dental pulp blood flow provides the most direct means to determine the viability of a tooth and is a vital piece of informatio ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  5. Ultrahigh-Bandwidth Robust Performance Diagnostics for Rotating Detonation Engines

    SBC: SPECTRAL ENERGIES LLC            Topic: AF19AT011

    Spectral Energies proposes to design a multisensory diagnostic suite for measurements within elevated-pressure RDEs. This sensor will utilize tunable-laser absorption spectroscopy to measure temperature, pressure and H2O concentrations in the annulus of a rocket-RDE and background-oriented schlieren imaging system for flow density gradient imaging to provide time resolved information about the sho ...

    STTR Phase I 2019 Department of DefenseAir Force
  6. High-Power, Ultra-low Noise, Heterogeneously Integrated Lasers

    SBC: Morton Photonics Incorporated            Topic: A14AT005

    In this program, Morton Photonics (MP) and its STTR partner Professor John Bowers and his research group at the University of California at Santa Barbara (UCSB) will develop two truly disruptive integrated laser devices: (1) A broadly tunable integrated laser with ultra-low linewidth, ultra-low relative intensity noise (RIN), and high output power; the Integrated Coherent Tunable Laser (ICTL), whi ...

    STTR Phase II 2019 Department of DefenseDefense Advanced Research Projects Agency
  7. An Advanced Lung Organomimetic to Reproduce Human Airway Pathophysiology

    SBC: PNEUMAX, LLC            Topic: 113

    PROJECT SUMMARYThree of top five causes of death in humans globally are lung relatedchronic obstructive pulmonary diseaseCOPDlower respiratory infections and lung cancers collectively account for over eight million deaths annuallyCurrentlyin preclinical settingstatic cell cultures and animal models are the most widely used systems for mechanistic and translational studiesHowevercritical limitation ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  8. Oral Enzymatic Management of Phenylketonuria

    SBC: ABRI SCIENCE, LLC            Topic: 300

    PhenylketonuriaPKUis a genetic disorder of metabolism characterized by a pathological elevation of phenylalaninePhein the body stemming from a dysfunctional phenylalanine hydroxylase enzymePAHThe resulting high concentrations of Phexcan result in severe intellectual disabilitybehavioral problemsand neurological deficitse gseizuresStrict control of dietary Phe is the primary treatment for PKU curre ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  9. Gallium 68 Tilmanocept for PET Imaging of Atherosclerosis Plaques

    SBC: Navidea Biopharmaceuticals, Inc.            Topic: NHLBI

    Myocardial infarctionsMIor heart attacksischemic strokesISand peripheral artery diseasePADtogether considered cardiovascular diseaseCVDare all commonly caused by the same underlying pathologyatherosclerosisMIs and ISs are the leading causes of death and disability worldwideAtherosclerosis is a progressive pathology that develops asymptomatically over the course of many years as inflammatory plaque ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  10. Targeting neurotoxic alpha-synuclein aggregates for Parkinson's disease therapy.

    SBC: Vova Ida, LLC            Topic: 999

    SUMMARYParkinsonandapos s diseasePDis the second most prevalent neurodegenerative disorder after Alzheimerandapos s diseaseADaffecting more thanmillion people in the United StatesBecause age is the major risk factorthe prevalence of both diseases is steadily increasing as our population agesPD belongs to the group of protein misfolding neurodegenerative diseases that are due to the misfolding and ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government